Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: No alteration in adipose tissue of obese and NIDDM patients

Diabetes

Volumn 46, Issue 8, 1997, Pages 1319-1327

  Auboeuf, Didier ^a   Rieusset, Jennifer ^a   Fajas, Lluis ^d   Vallier, Paulette ^a   Frering, Vincent ^b,c   Riou, Jean Paul ^a   Staels, Bart ^d   Auwerx, Johan ^d   Laville, Martine ^a   Vidal, Hubert ^a  

^a INSERM   (France)

^b R Laënnec Faculty of Medicine   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; INSULIN; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR; THIAZOLIDINE DERIVATIVE;

ADIPOSE TISSUE; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LARGE INTESTINE; LIPID METABOLISM; LIVER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0030747895     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.8.1319     Document Type: Article

References (46)

1. Howard BH, Howard WJ: Dyslipidemia in non-insulin-dependent diabetes mellitus. Endocr Rev 15:205-216, 1994
2. Frayn KN, Williams CM, Amer P: Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci 90:243-253, 1996
3. Schoonjans K, Staels B, Auwerx J: The peroxisome proliferator activated receptor and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302:93-109, 1996
4. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156, 1994
5. De Vos P, Lefebvre AM, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J: Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ. J Clin Invest 98:1004-1009, 1996
6. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
7. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM: Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptor. Nature 358:771-774, 1992
8. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W: Differential expression of peroxisome proliferator-activated receptors: tissue distribution of PPARα, β and γ in the adult rat. Endocrinology 137:354-366, 1996
9. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91:7355-7359, 1994
10. Devchand PV, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W: The PPARα leukotriene B4 pathway to inflammation control. Nature 384:39-43, 1996
11. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK: Structural organization of mouse peroxisome-activated receptor γ gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 92:7921-7925, 1995
12. Eibrecht A, Chen Y, Cullinan CA, Hayes N, Leibowitz MD, Moller DE, Berger J: Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun 224:431-437, 1996
13. Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, Spiegehnan B, Flier JS, Moller DE: Regulation of PPARγ gene expression by nutrition and obesity in rodents. J Clin Invest 97:2553-2561, 1996
14. 12-14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812, 1995
15. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM: A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83:813-819, 1995
16. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ. J Biol Chem 270:12953-12956, 1995
17. Teboul L, Gaillard D, Staccini L, Inadera H, Amri EZ, Grimaldi PA: Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J Biol Chem 270:28183-28187, 1995
18. Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, Kraegen EW: A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat Diabetes 43:1203-1210, 1994
19. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J: Troglitazone in obese subjects whithout diabetes. N Engl J Med 331:1188-1193, 1994
20. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ: LXRα nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9:1033-1045, 1995
21. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ: An oxisterol signailing pathway mediated by the nuclear receptor LXRα. Nature 383:728-731, 1996
22. Miyata KS, McCaw SE, Patel HV, Rachubinski RA, Capone JP: The orphan nuclear receptor LXRα interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferation signaling. J Biol Chem 271:9189-9192, 1996
23. Laville M, Auboeuf D, Khalfallah Y, Vega N, Riou JP, Vidai H: Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut4 and lipoprotein lipase mRNA levels in human muscle. J Clin Invest 98:43-49, 1996
24. Vidal H, Auboeuf D, De Vos P, Staels B, Riou JP, Auwerx J, Laville M: The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest 98:251-255, 1996
25. Auboeuf D, Vidal H: The use of the reverse transcription-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples. Anal Biochem 245:141-148, 1997
26. Sher T, Yi HF, McBride OW, Gonzalez FJ: cDNA cloning, chromosomal mapping and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32:5598-5604, 1993
27. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA:; Identification of a new member of the steroid hormone receptor superfamily that is activated by aperoxisome proliferator and fatty acids. Mol Endocrinol 6:1634-1641, 1992
28. Rodbell M: Metabolism of isolated fat cells. J Biol Chem 239:375-380, 1964
29. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob mRNA in obese and weight-reduced subjects. Nature Med 1:1155-1161, 1995
30. Schoonjans K, Peinado-Onsurbe J, Lefebvre A-M, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J: PPARa and PPARγ activators direct a distinct tissue-specific transcriptional response via PPRE in the lipoprotein lipase gene. EMBO J 15:5336-5348, 1996
31. Lambe KG, Tugwood JD: A human peroxisome proliferator-activated receptor gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur J Biochem 239:1-7, 1996
32. Mukherjee R, Jow L, Noonan D, McDonnell DP: Human and rat peroxisome proliferator activated receptors demonstrate similar tissue distribution but different responsiveness to PPAR activators. J Steroid Biochem Mol Biol 51:157-166, 1994
33. Jones PS, Savory R, Barratt P, Bell AR, Gray TJ, Jenkins NA, Gilbert DJ, Copeland NG, Bell DR: Chromosomal localisation, inducibuity, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated receptor genes. Eur J Biochem 233:219-226, 1995
34. Lee ST, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ: Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012-3022, 1995
35. Jow L, Mukherjee R: The human peroxisome proliferator-activated receptor subtype NUC1 represses the activation of hPPARα and thyroid hormone receptors. J Biol Chem 270:3836-3840, 1995
36. Mansen A, Guardiola-Diaz H, Rafter J, Branting C, Gustafsson JA: Expression of the peroxisome proliferator-activated receptor in the mouse colonic mucosa. Biochem Biophys Res Commun 222:844-851, 1996
37. Giovanucci E, Willet WC: Dietary factors and risk of colon cancer. Ann Med 26:443-452, 1994
38. Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Keeskemeti K, Gramlich TL, Beeken W: Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 116:609-614, 1992
39. Belluzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M: Effect of an enteric-coated fish-oil preparation on relapses in Crohns disease. N Engl J Med 334:1557-1560, 1996
40. Pearson SL, Cawthorne MA, Clapham JC, Dunmore SJ, Holmes SD, Moores GBT, Smith SA, Tadayyon M: The thiazolidinedione insulin sensitiser BRL 49653, increases the expression of PPARγ and aP2 in adipose tissue of high-fat-fed rats. Biochem Biophys Res Commun 229:752-757, 1996
41. Juge-Aubry CE, Gorla-Bajszczak A, Pernin A, Lemberger T, Wahli W, Burger AG, Meier CA: Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. J Biol Chem 270:18117-18122, 1995
42. Bogazzi F, Hudson LD, Nikodem VM: A novel heterodimerization partner for thyroid hormone receptor. J Biol Chem 269:11683-11686, 1994
43. Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glasss CK, Rosenfeld MG: Ugand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-403, 1995
44. Shalev A, Siegrist-Kaiser CA, Yen PM, Wahli W, Burger AG, Chin WW, Meier CA: The peroxisome proliferator-activated receptor α is a phosphoprotein: regulation by insulin. Endocrinology 137:4499-4502, 1996
45. Hu E, Kim JB, Sarraf P, Spiegelman BM: Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274:2100-2103, 1996
46. Lemberger T, Saladin R, Vazquez M, Assimacopoulos F, Staels B, Desvergne B, Wahli W, Auwerx J: Expression of the peroxisome proliferator-activated receptor a gene is stimulated by stress and follows a diurnal rhythm. J Biol Chem 271:1764-1769, 1996